Published
This week in Hematology: Sanofi’s Sarclisa moves closer to front-line approval in multiple myeloma, while new research underscores the impact of genetic ancestry on T-ALL outcomes. Revuforj receives FDA Priority Review for mutant NPM1 AML, and SGR-1505 gains Fast Track for Waldenström’s. EO2463 shows strong response in lymphoma, and NXT007 and HYMPAVZI report major hemophilia advances. BioMarin’s ROCTAVIAN demonstrates durable 5-year efficacy, and Cellarity launches a first-in-class sickle cell therapy. Plus, BRUKINSA’s tablet form nears EU approval. Stay informed with LucidQuest
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
08:01
BOOK REVIEW ~ The Psychology Of Money by Morgan Housel | Review by Hariharan Iyer
-
05:35
University Hospitals Hematology-Oncology Fellowship Program
-
04:14
Hematology Oncology: Ask Dr. Rumaisa Hameed
-
08:46
Global Pediatric Hematology & Oncology Chat | Episode 3
-
19:42
Hematology Oncology - Normal Hemostasis
-
05:34
Hematology and Oncology Overview
-
06:14
Hodgkin's Lymphoma/ hematology/ Davidson summarised
-
04:19
Hematology Advances: Sarclisa EU Nod, Revuforj Review, HYMPAVZI & More
-
15:11
ABIM Hematology & Oncology: Mastering Exams with ChatGPT (Ep.1)
-
07:39
In the Know: Getting to Know Hematology-Oncology
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
